![](/img/cover-not-exists.png)
EPHA2 Is a Mediator of Vemurafenib Resistance and a Novel Therapeutic Target in Melanoma
Miao, B., Ji, Z., Tan, L., Taylor, M., Zhang, J., Choi, H. G., Frederick, D. T., Kumar, R., Wargo, J. A., Flaherty, K. T., Gray, N. S., Tsao, H.Volume:
5
Language:
english
Journal:
Cancer Discovery
DOI:
10.1158/2159-8290.CD-14-0295
Date:
March, 2015
File:
PDF, 1.60 MB
english, 2015